TY - JOUR
T1 - Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients
AU - INVERNIZZI, MARCO
AU - Venetis, K.
AU - Sajjadi, E.
AU - Piciotti, R.
AU - de Sire, A.
AU - Fusco, N.
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021
Y1 - 2021
N2 - Muscle maintenance relies on a multidimensional biologic balance that is extremely delicate in breast cancer patients, particularly those with advanced-stage disease. The biology that underpins breast cancer tumorigenesis, tumor progression and response to pharmacotherapies can modify muscle homeostasis, resulting in volumetric muscle loss. This condition dramatically increases the overall patients’ frailty, leading to reduced survival and impaired quality of life. Physical activity may potentially improve muscle health in these patients, providing that an optimal patients selection is performed. The understanding of volumetric muscle loss biology in breast cancer survivors, coupled with focused clinical studies, would allow for the implementation of individualized rehabilitation protocols.
AB - Muscle maintenance relies on a multidimensional biologic balance that is extremely delicate in breast cancer patients, particularly those with advanced-stage disease. The biology that underpins breast cancer tumorigenesis, tumor progression and response to pharmacotherapies can modify muscle homeostasis, resulting in volumetric muscle loss. This condition dramatically increases the overall patients’ frailty, leading to reduced survival and impaired quality of life. Physical activity may potentially improve muscle health in these patients, providing that an optimal patients selection is performed. The understanding of volumetric muscle loss biology in breast cancer survivors, coupled with focused clinical studies, would allow for the implementation of individualized rehabilitation protocols.
UR - https://iris.uniupo.it/handle/11579/127397
U2 - 10.1016/j.coph.2021.03.007
DO - 10.1016/j.coph.2021.03.007
M3 - Article
SN - 1471-4892
VL - 58
SP - 27
EP - 34
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
ER -